Case number 1:22-cv-01405
Astrazeneca AB et al v. Taro Pharmaceuticals U.S.A., Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 9, 2022 | 13 | AO 120 Form Patent - Case Terminated - Submitted (3) Docket Text: AO 120 FORM PATENT - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 3/8/2022 in a court action filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (tp) |
| Mar 8, 2022 | N/A | Notice to Attorney Regarding Deficient Voluntary Dismissal (0) Docket Text:***NOTICE TO ATTORNEY REGARDING DEFICIENT VOLUNTARY DISMISSAL. Notice to Attorney Wallach, Margarita. RE-FILE Document No. [11] Notice of Voluntary Dismissal,,. The filing is deficient for the following reason(s): the wrong party/parties whom the voluntary dismissal is against was/were selected;. Re-file the document using the event type Notice of Voluntary Dismissal found under the event list Notices - select the correct filer/filers - select the correct party/parties the voluntary dismissal is against - and attach the correct signed PDF. (nd) |
| Mar 8, 2022 | 12 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice and without costs against the defendant(s) Taro Pharmaceuticals U.S.A., Inc.. Document filed by Astrazeneca AB, Astrazeneca Pharmaceuticals LP. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Wallach, Margarita) |
| Mar 7, 2022 | 11 | Notice of Voluntary Dismissal (2) Docket Text: FILING ERROR - DEFICIENT DOCKET ENTRY - NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice and without costs against the defendant(s) Astrazeneca AB, Astrazeneca Pharmaceuticals LP. Document filed by Astrazeneca AB, Astrazeneca Pharmaceuticals LP. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Wallach, Margarita) Modified on 3/8/2022 (nd). |
| Feb 22, 2022 | N/A | Notice to Attorney to Re-File Document - Deficient Docket Entry Error (0) Docket Text:***NOTICE TO ATTORNEY TO RE-FILE DOCUMENTS - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Margarita Wallach to RE-FILE Documents [3] Rule 7.1 Corporate Disclosure Statement and [4] Rule 7.1 Corporate Disclosure Statement,. ERROR(S): Corporate Parents were not added. Please re-file these documents and when prompted: Are there any corporate parents or other affiliates?, select the YES radio button and enter the Corporate Parent(s) or Affiliate(s). YOU MUST SELECT THE SEARCH BUTTON. Select the correct name or create a new corporate parent. Add the Corporate Parent(s) or Affiliate(s) one party name at a time. (lb) |
| Feb 22, 2022 | N/A | Case Opening Initial Assignment Notice (0) Docket Text: CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Vernon S. Broderick. Please download and review the Individual Practices of the assigned District Judge, located at https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at https://nysd.uscourts.gov/rules/ecf-related-instructions..(pc) |
| Feb 22, 2022 | N/A | Case Designation (0) Docket Text: Magistrate Judge Stewart D. Aaron is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pc) |
| Feb 22, 2022 | N/A | Case Designated ECF (0) Docket Text: Case Designated ECF. (pc) |
| Feb 22, 2022 | 7 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceuticals U.S.A., Inc...(pc) |
| Feb 22, 2022 | 8 | Rule 7.1 Corporate Disclosure Statement (2) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Astrazeneca PLC for Astrazeneca AB. Document filed by Astrazeneca AB..(Wallach, Margarita) |
| Feb 22, 2022 | 9 | Rule 7.1 Corporate Disclosure Statement (2) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Astrazeneca PLC for Astrazeneca Pharmaceuticals LP. Document filed by Astrazeneca Pharmaceuticals LP..(Wallach, Margarita) |
| Feb 22, 2022 | 10 | Mail Patent Form (case opening) (1) Docket Text: AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF)..(pc) |
| Feb 18, 2022 | 1 | Main Document (10) Docket Text: COMPLAINT against Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 402.00, Receipt Number ANYSDC-25755697)Document filed by Astrazeneca AB, Astrazeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A).(Wallach, Margarita) |
| Feb 18, 2022 | 1 | Exhibit A (76) |
| Feb 18, 2022 | 2 | Civil Cover Sheet (2) Docket Text: CIVIL COVER SHEET filed..(Wallach, Margarita) |
| Feb 18, 2022 | 3 | Rule 7.1 Corporate Disclosure Statement (2) Docket Text: FILING ERROR - CORPORATE PARENT/OTHER AFFILIATE NOT ADDED - RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Astrazeneca AB..(Wallach, Margarita) Modified on 2/22/2022 (lb). |
| Feb 18, 2022 | 4 | Rule 7.1 Corporate Disclosure Statement (2) Docket Text: FILING ERROR - CORPORATE PARENT/OTHER AFFILIATE NOT ADDED - RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Astrazeneca Pharmaceuticals LP..(Wallach, Margarita) Modified on 2/22/2022 (lb). |
| Feb 18, 2022 | 5 | AO 120 Form Patent/Trademark - Notice of Submission by Attorney (1) Docket Text: AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review..(Wallach, Margarita) |
| Feb 18, 2022 | 6 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceuticals U.S.A., Inc., re: [1] Complaint. Document filed by Astrazeneca AB, Astrazeneca Pharmaceuticals LP..(Wallach, Margarita) |
| Feb 18, 2022 | 1 | Complaint* (1) |
